Caitlin(Sanstead)ZebleyMDPhD

Pediatric Hematology & Oncology • Memphis, TN

Physician

Join to view full profile

Dr. Zebley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Zebley's full profile

Already have an account?

Office
262 Danny Thomas Pl
Memphis, TN 38105
Phone+1 901-595-3300

Education & Training

University of MinnesotaResidency, Pediatrics, 2012 - 2015
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2012
University of TennesseeFellowship, Pediatric Hematology/Oncology
St. Jude Graduate School of Biomedical Sciences PhD, Immunology

Certifications & Licensure

TN State Medical License 2016 - 2026
MN State Medical License 2013 - 2016
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Publications & Presentations

PubMed

106 citations
Human memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasis
Hossam A. Abdelsamed, Ardiana Moustaki, Yiping Fan, Pranay Dogra, Hazem E. Ghoneim
The Journal of Experimental Medicine. 2017-06-05
66 citations
Beta cell-specific CD8+ T cells maintain stem cell memory-associated epigenetic programs during type 1 diabetes
Hossam A. Abdelsamed, Caitlin C. Zebley, Hai Nguyen, Rachel L. Rutishauser, Yiping Fan
Nature Immunology. 2020-03-30
2 citations
T cell dysfunction and therapeutic intervention in cancer.
Caitlin C Zebley, Dietmar Zehn, Stephen Gottschalk, Hongbo Chi
Nature Immunology. 2024-08-01

Abstracts/Posters

Engineering Naturally Occurring CD7 Negative Cells for the Immunotherapy of CD7 Positive Leukemia
Caitlin Zebley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

Disruption of Asxl1 Gene Improves Tumor Control in ImmunotherapyOctober 11th, 2024
Disrupting Asxl1 Gene Prevents T-cell Exhaustion, Improving ImmunotherapyOctober 10th, 2024
Ava's Army Supports Alex's Lemonade Stand Foundation in Funding High-Impact Research in Pediatric LeukemiaMarch 22nd, 2022
Join now to see all